Skip to main content

Table 2 Proportions of the eligible populations with colonoscopy/FOBT, mammography or PSA testing in 2014, 2016, and 2018, and significance tests of change of these proportions, pairwise between years

From: Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study

  2014 2016 2018 Change in proportion 20,142,016 pa Change in proportion 2016–2018 pa Change in proportion 2014–2018 pa
colonoscopy/ FOBTb 8.3% 8.9% 9.2% 0.7% < 0.001 0.2% 0.003 0.9% < 0.001
mammography 20.9% 21.2% 20.4% 0.3% 0.017 −0.8% < 0.001 −0.5% < 0.001
PSA testingc 30.5% 31.1% 31.8% 0.5% 0.001 0.7% < 0.001 1.2% < 0.001
  1. a using Chi-squared tests
  2. b FOBT Fecal occult blood testing
  3. c PSA Prostate-specific antigen